Connect with us

Regulations

Hemp Test Puts CBD Seller to Jail

Published

on

Hemp Test sends CBD seller to jail

A Lehigh County resident is put behind bars following a cannabis test that showed above allowable THC level on his deliverable goods, causing confusion on hemp legalization in the state of Pennsylvania.

Pennsylvania State Police seized suspicious package reeking of the distinct marijuana smell last February 27 and April 4. The said goods were shipped from an Allentown business address of a certain Kenneth Grossman, which was set to be received at a New York address.

Law enforcers found unknown substances filled in packets and jars, which they suspected to contain cannabidiol or CBD. The CBD is a chemical derived from hemp flower, which contains medicinal properties like pain relief.

CBD in Pennsylvania

Despite the Food and Drug Administration still tying strings for CBD regulation, several pharmacies and stores in Pennsylvania are already selling CBD-infused items like sweets, lotions, and sprays.

Although CBD is known to be non-psychoactive, the samples that were found to contain THC, the chemical responsible for a marijuana user’s high.

Hemp, which is sourced from the same plant species as marijuana, is considered a legal crop provided that it only has trace THC amount of less than 0.3%.

More about the Case

Standard police field test for suspicious goods only determine THC presence and not the concentration.

Grossman’s storage unit and vehicle were searched by police last May 29; some of the items seized include CBD-containing candies and other CBD products.

Drug-sniffing dog from Pennsylvania police pinned the storage unit, and the sample sent to the laboratory came back positive. It was noted that the inventory sheet did not mention marijuana or THC.

Grossman was seized and charged on account of criminal conspiracy relating to illegal substances.

Detailed lab reports and product packaging later revealed that the THC on the products didn’t go over 0.3% allowable amount. Jordan Sonka, a police trooper, stated during the trial that he cannot verify the truth in such claims.

Grossman’s son Jason introduced his father to CBD. Grossman doubted the chemical’s legality, but Jason insisted that the laws have recently changed. They attended a number of trade shows and planned to acquire a warehouse for later use.

Both father and son told Sonka upon interrogation that they were in the early phase of establishing a wholesale distribution enterprise for CBD products.

Neither of them was a hemp cultivator but are only resellers, ordering products from a certain Jamal who was also only a distributor from Oregon who bought his supplies from local farmers.

Sonka stated that the Grossman’s retailers were mainly gas stations and stores in the locale, and as well as to New York and DC connections. He also questioned the legality of the Grossman’s business, New Labs, due to lack of registration details in police databases and internet search.

However, the suspects’ Attorney James Heidecker was able to present a business license from Allentown during a preliminary trial last June. Heidecker made snide remarks on Snoka for failing to check the business’ validity in Allentown, where the accused actually resided.

Gray Areas in the Field Test

Hemp sat at the federal government’s Controlled Substances roster for a long time, despite it not having psychotropic traits. It was only after the 2018 Farm Bill that industrial hemp got delisted and instated as an agricultural crop.

However, one case from Idaho still saw a trucker hauling hemp from Oregon being arrested after a drug-sniffing dog and field test showed positive for THC.

These methods are currently rendered impractical, as a simple test strip cannot gauge the THC level of a product, states National Hemp Association Chairman Geoffrey Whaling. He further stated that the state should clarify its law on controlled substance law to clear up the air regarding hemp legalization.

Although the bill to permit hemp-infused products is yet to be taken up, hemp cultivators from the state are protected by the existing mandate in relation to the Farm Bill.

Before a farmer is allowed to grow hemp, they must be licensed, their plants tested for THC levels, and their fields tracked with GPS coordinates.

On the other hand, no permits are needed to sell and trade hemp products.

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Regulations

Is Charlotte’s Web in Trouble After Recent CBD Warning by FDA?

Published

on

The cannabidiol industry is set towards an impressive expansion. According to a research firm forecast, CBD sales could reach $20B by 2024, almost tenfold from 2018’s sales of $1.8B. It could be attributed to upward trends in the industry, and as well as the great reception to CBD being a safe option compared to marijuana due to its low tetrahydrocannabinol (THC) content. THC is the substance responsible for the high in weed.

However, the Food and Drug Administration (FDA) has issued a warning recently that stated how some CBD-based products could cause serious health problems. This statement might affect one of the leading CBD companies in the US, Charlotte’s Web Holdings.

CBD may not always be healthy

In a consumer update published by the FDA regarding CBD product use, the agency stressed that cannabidiol might be the cause for various health issues such as liver injury, change in mood, and alertness. CBD used with other depressants and alcohol may also cause drowsiness. The FDA added that the said side effects could happen even without the user noticing.

The agency also reiterated that the alleged therapeutic benefits of cannabidiol are mostly unproven, despite several sellers highlighting their products as having several health benefits such as anti-cancer and pain-relieving properties.

The FDA also reminded the public that there is still a lack of data as CBD’s effects on the body in the long term. It is something consumers should ponder about according to the agency.

Is Charlotte’s Web Affected?

Charlotte’s Web is one of the most well-known US-based cannabidiol companies in the country and abroad. It sells a variety of CBD-containing products such as capsules and oil. It claims the biggest US market share in the CBD industry, with its products selling at nearly 10,000 stores nationwide. Its strong retail presence aids in the expansion of the company’s market share. Can the FDA warning affect their numbers?

Most likely not, and Charlotte’s Web can still maintain its top market position. The FDA has sent out warning letters to companies selling CBD products with false promotional claims, but Charlotte’s Web was not included. In a conference call of Charlotte’s Web CEO Deanie Elsner regarding their third-quarter earnings, he specified that the company fully supports the FDA’s stance on unfounded claims and are working with their business partners to maintain the effort.

Elsner also mentioned that while the FDA has little issuance on regulations, Charlotte’s Web is ready to adapt as soon as new directives from the agency are released. He said that the company is currently progressing on its expansion plan, getting its infrastructure and capacity to catch up with its growth.

The company is rooting for the FDA to set a clear regulatory framework, especially for dietary supplements. Charlotte’s Web is positive that its product portfolio and distribution channels will expand as soon as it happens.

The CBD industry looks to persist despite the warnings, and the supply of products will unlikely dwindle. Charlotte’s Web and its growth will remain unaffected. For investors, it might be wise to keep in mind that the CBD legal landscape is still an unfinished course, so evaluating whether a company is worth purchasing shares from is important.

Continue Reading

Regulations

China Cashes in on Cannabis Boom Despite Being Illegal in the Country

Published

on

China Cashes in on Cannabis Boom

Marijuana is a dangerous narcotic in China, and being caught possessing it incurs a grave offense. However, this does not hamper the booming production of cannabis products in the region.

China has been growing hemp for textile and alternative medicine for many centuries and remains to be one of the largest top producers in the world. The giant’s footing in the cannabis industry has given producers an edge in the booming CBD craze. CBD or cannabidiol is a derivative of the cannabis plant that is now infused in virtually anything, from pet products to skincare serums.

The heart of the production

Yunnan, a province in China’s southwestern region, is the first to make industrial cannabis legal. The farm plots in the area are filled with tall hemp fields that span miles. The plant’s flowers and leaves are harvested by hand during the fall, sun-dried, and then turned into export quality CBD oil and powder. Yang Liu, manager of some hemp fields in Qujing, Yunnan, said that the cannabis industry looks to bring great benefit to him and the farmers in the future.

China holds 11% of the $800M worldwide CBD market last year, trailing after the US and Europe.

The industry is still maturing, but manufacturers and other key players in the CBD market are investing in land to increase hemp production. It may have existed for thousands of years, but hemp growing wasn’t adequately regulated until recently, with the government now being intimately involved in the development of the CBD industry.

Henri Sant-Cassia, a CBD advocate representing Cannabis Fund who tours Asia to find new CBD enterprises, exclaimed that China is moving into the cannabidiol industry at the speed of light.

Unbending regulations

Farmers in the US are also upping their hemp cultivation to cope with the rising CBD demand. This cannabis derivative is said to relieve anxiety and pain without causing a high that marijuana gives. The Brightfield Group predicts the CBD market to grow to a $23.7B industry by 2023.

Despite the astounding numbers, China’s stance on marijuana is unlikely to bend. If anyone is found to be harboring tetrahydrocannabinol (THC)-based products, they can be charged with a life sentence or worse, the death penalty. National Narcotics Control Commission deputy director Liu Yuejin said last April that China would strictly supervise industrial cannabis production amid its legalization in many countries.

Ingestible CBD is also regulated in China, which means that almost all hemp harvested and processed in China is sent overseas. It competes with other major hemp producers like Canada and the US for CBD market share.

CBD industry in China

The second province to legalize industrial cannabis farming is Heilongjiang, which is located along the Siberian border in the country’s northeastern area. Neighboring province Jilin is also poised to follow in their footsteps. Government officials are starting to encourage growers to consider hemp production, citing additional income and crop diversification as the benefits.

An influx of new companies entered China’s CBD industry recently, which Hanma Investment Group Co. Co-Founder Tan Xin believes will make it harder for newcomers to gain profit.

Since HMI started their cannabis venture in 2013, a kilo of CBD was valued at $50,000 when sold in the US, as stated by Tan Xin. In 2018, it fell to $6,000 and would most likely drop to $1,000 per kilo in 2020, according to him.

Nevertheless, Tan is positive that they can still cash in, provided that the price does not fall below the $300 mark since processing and labor cost less in China.

Continue Reading

Regulations

Untested CBD-infused Products Could Pose Health Risks as Market Grows Stronger

Published

on

Untested CBD-infused Products Could Pose Health Risks

Cannabidiol products have recently spiked in sales and availability, granted by its popularity as an alternative cure to anxiety and pain. However, medical authorities warn about the potential health hazards of CBD and the many unproven therapeutic claims of the said substance.

Cronos, a Canadian company, recently bought a $300M CBD company, 7-Eleven stores now have CBD-dispensing robots, and HempAmericana Inc. started a live e-commerce portal to foster online CBD sales.

Expert’s opinion

Dr. Dipesh Navsaria, director of the University of Wisconsin’s Doctor of Medicine-Master of Public Health Program, stated that cannabidiol might have numerous benefits, but most of these claims have not been tested for accuracy.

He cited the clinical trials of CBD for intractable seizures as the only benefit proven to be true. Intractable epilepsy is a kind of seizure that does not respond to therapy or any treatment. The CBD-containing drug, Epidiolex, is the only FDA-approved cannabidiol medication given for such cases.

Navsaria reiterated that several claims lack strong evidence for them to count.

Earlier this year, the FDA gave out warning letters to companies that sell new yet unapproved drugs that allegedly have CBD. Three of these firms are located in Florida.

CBD is widely available in stores and online, including big retailers like Walgreens.

Navsaria pointed out the lack of guarantee in terms of a product’s purity, and its active ingredients are what make it hard for medical practitioners to say yes to patients asking whether they can try CBD. It’s is the same dilemma they face for homeopathic remedies and herbal supplements, Navsaria added.

Research on CBD

Forbes revealed cases of people testing positive in urine drug tests from using CBD. This situation poses a risk for people whose jobs stipulate routine drug testing.

Natalie Schmitz, associate professor at the University of Wisconsin School of Pharmacy, studied the labeling accuracy for CBD products in her research. She stated that the literature related to CBD is limited and cannot support the claims of effectiveness.

She added that further research should be done to support all claims, including the benefits of CBD for pain and anxiety so that a conclusive statement can be made.

Some studies show how CBD can cause liver problems. There is also evidence of the substance causing several side effects like irritability, fatigue, and nausea.

Schmitz further stated that there is a need for FDA-approved guidelines for standardization and state-proposed quality measurements to help ensure that CBD products do not pose health hazards for the public.

Navsaria said that people should question products that are claiming to have several benefits without proper evidence. He cited profit motive as a drive for the proliferating CBD market. He believes that sellers are taking advantage of the trend to maximize sales, making it questionable whether these products are actually made to help people.

He further added that claims could easily be made, but there is little to no support over its factual value.

Continue Reading

Trending